Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

The Blood-brain Barrier

The Blood-brain Barrier

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The relationship between cognitive and reading skills in typically developing pre-primary school children.

Frontiers in behavioral neuroscience·2026

Same author

Bridging dream and wake states: a new tool for consciousness research.

Neuroscience of consciousness·2026

Same author

Circadian rhythm disruption impairs time-dependent dentine regeneration and reprograms the late-stage dental proteome in a mouse pulp injury model.

Frontiers in pharmacology·2026

Same author

Transcranial alternating current stimulation improves cognitive functions in healthy subjects through modifying frontoparietal and dorsal attention networks based on personalized individual theta frequency analysis.

Frontiers in behavioral neuroscience·2026

Same author

Resting-state EEG microstates link neural dynamics to fluid intelligence in mild cognitive impairment.

Frontiers in aging neuroscience·2026

Same author

Abnormal periodic and aperiodic resting-state electroencephalographic markers in Lewy body and Alzheimer's diseases with cognitive decline.

GeroScience·2026

Search research articles

Related Experiment Video

Updated: Apr 28, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

RIFAMPICIN: an antibiotic with brain protective function.

Burak Yulug¹, Lütfü Hanoglu¹, Ertugrul Kilic²

¹Department of Neurology, University of Istanbul-Medipol, Istanbul, Turkey.

Brain Research Bulletin

|June 7, 2014

Summary

Rifampicin, known for antibiotic properties, also protects the brain in conditions like stroke and neurodegenerative diseases. This review updates its unique therapeutic potential in various brain disorders.

Keywords:

Alzheimer's disease Meningitis Optic nerve injury Parkinson's disease Rifampicin Stroke

More Related Videos

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

Related Experiment Videos

Last Updated: Apr 28, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

Area of Science:

Neuroscience
Pharmacology
Neurology

Background:

Rifampicin is primarily recognized for its antibiotic properties.
Emerging evidence suggests significant neuroprotective roles for rifampicin.
These roles extend to both acute and chronic neurological conditions.

Purpose of the Study:

To provide an updated review of rifampicin's unique brain protective functions.
To explore its therapeutic potential in diverse neurological diseases.
To consolidate current knowledge on rifampicin's neuroactivity.

Main Methods:

Literature review of existing studies on rifampicin and neurological conditions.
Analysis of research data on rifampicin's mechanisms in brain protection.
Synthesis of findings related to its efficacy in various disease models.

Main Results:

Rifampicin demonstrates neuroprotective effects in acute cerebral ischemia (stroke).
It exhibits beneficial functions in chronic neurodegenerative conditions.
Specific diseases highlighted include Parkinson's disease, meningitis, Alzheimer's disease, and optic nerve injury.

Conclusions:

Rifampicin possesses multifaceted brain protective capabilities beyond its antibiotic action.
Its unique activity warrants further investigation for treating a spectrum of neurological disorders.
Rifampicin represents a promising therapeutic agent for neurological diseases.